by Co-Diagnostics | Jan 31, 2019 | News Release
SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into definitive agreements with... by Co-Diagnostics | Jan 30, 2019 | News Release
Transaction included $3M of preferred shares, and the elimination of $2M of debt SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular... by Co-Diagnostics | Jan 23, 2019 | News Release
Presentation coincided with launch of a private-label CoPrimer Product SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,... by Co-Diagnostics | Jan 10, 2019 | News Release
Company Senior Research Scientist will be a guest speaker of LGC, Biosearch SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,... 